COMPOSITION AND USE OF ENGINEERED MONOCLONAL ANTIBODIES REFRACTORY TO TUMOR IMMUNO-SUPPRESS… Application WO-2021138346-A1 World Intellectual Property Organisation (WIPO) 08 Jul 2021